IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Straus, D C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Straus, D C

 Previous Article  |  Next Article 

Infect Immun. 1987 January; 55(1): 44-48

Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.

D C Straus

ABSTRACT

Six isolates of Klebsiella pneumoniae (two serotype 1 isolates and a capsular variant of one of these, and two serotype 2 isolates and a capsular variant of one of these) possessing various degrees of virulence in rats and mice were examined for their in vitro production of an extracellular toxic complex (ETC). The ETC has been shown to be lethal for and produce extensive lung pathology in mice. This compound has been shown to be composed of capsular polysaccharide, lipopolysaccharide, and a small amount of protein. All six isolates produced the ETC. Immunization of experimental animals with sublethal doses of the ETC was protective against both homologous and heterologous strains, and this protection was due to antibody production. An examination of the various phases of growth of K. pneumoniae showed that there was extracellular release of the component parts of the ETC occurring during all phases of growth. The presence of the ETC in the supernatant fluids was due to actual release of this material as opposed to cell lysis. Antibodies to the lipopolysaccharide portion (which has been shown to possess the observed toxicity) of the ETC were protective against the homologous bacterium.


Infect Immun. 1987 January; 55(1): 44-48




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1987 by the American Society for Microbiology. All rights reserved.